Log in to save to my catalogue

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5660a090c38e4b3b940cc272796da086

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury

About this item

Full title

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury

Publisher

England: BioMed Central Ltd

Journal title

Journal for immunotherapy of cancer, 2019-02, Vol.7 (1), p.31-12, Article 31

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Immune checkpoint inhibitor (ICI)-induced pancreatic injury (ICIPI) is not well documented in the literature. We aimed to describe the clinical characteristics and outcomes of patients who developed ICIPI.
We reviewed the medical records of consecutive patients who had a confirmed diagnosis of ICIPI (Common Terminology Criteria for Adverse Event...

Alternative Titles

Full title

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5660a090c38e4b3b940cc272796da086

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5660a090c38e4b3b940cc272796da086

Other Identifiers

ISSN

2051-1426

E-ISSN

2051-1426

DOI

10.1186/s40425-019-0502-7

How to access this item